Keith A. Kucinski
2019
In 2019, Keith A. Kucinski earned a total compensation of $626.6K as Chief Financial Officer at Matinas BioPharma Holdings.
Compensation breakdown
| Option Awards | $377,542 |
|---|---|
| Salary | $249,053 |
| Total | $626,595 |
Kucinski received $377.5K in option awards, accounting for 60% of the total pay in 2019.
Kucinski also received $249.1K in salary.
Rankings
In 2019, Keith A. Kucinski's compensation ranked 11,074th out of 13,971 executives tracked by ExecPay. In other words, Kucinski earned more than 20.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,074 out of 13,971 | 21st |
Division Manufacturing | 4,481 out of 5,695 | 21st |
Major group Chemicals And Allied Products | 1,753 out of 2,194 | 20th |
Industry group Drugs | 1,507 out of 1,880 | 20th |
Industry Pharmaceutical Preparations | 1,115 out of 1,392 | 20th |
Source: SEC filing on October 1, 2020.
Kucinski's colleagues
We found four more compensation records of executives who worked with Keith A. Kucinski at Matinas BioPharma Holdings in 2019.